Mitogenic signal deficiency induces CD133+ vesicles.(A and B) Immunofluorescence on in vitro colonies of primary hepatocytes from Shp2 knockout (SKO) liver. CD133 was localized at filament-like structures in E-Cad+ colonies as shown by arrowheads in (A), which were connected between different hep...
more
Mitogenic signal deficiency induces CD133+ vesicles.(A and B) Immunofluorescence on in vitro colonies of primary hepatocytes from Shp2 knockout (SKO) liver. CD133 was localized at filament-like structures in E-Cad+ colonies as shown by arrowheads in (A), which were connected between different hepatocytes as shown by arrows in (B). (C) 3D-reconstituted confocal image of immunofluorescence on PLC cells. Lower panel shows the Z-plane section of the orange box area. Arrowheads indicate the CD133 signal on continuous filament-like structures bridged between neighboring cells. Pink dashed lines indicate the cell surface. (D) Immunofluorescence of MCF10A cells treated with Shp2 inhibitor. (E and F) Super-resolution STORM images of immunofluorescence on PLC cells without (E) or with (F) CD133 overexpression. Colocalization of CD133 and β-tubulin was analyzed as Pearson’s coefficient. Mismatched green and magenta channels from shuffled ROIs were measured as controls (Figure S4E). Means ± SEM from six images are shown. **p<0.01, ***p<0.001 (two-tailed unpaired t-test). (G) Immunofluorescence and Immuno-Gold EM images of cryo-ultramicrotome sections of SKO liver tissue after partial hepatectomy (PHx). Cyan arrowheads and asterisk indicate apical lumens. White arrowheads indicate the CD133 signals aligned between the apical lumens of neighboring cells. Light green arrow, CD133 staining (12 nm colloidal gold); Magenta arrows, α-tubulin staining (18 nm colloidal gold). (H) Immunoblotting of CD133+ vesicles isolated from MEK inhibitor (MEKi) -treated PLC cells. Markers for different fractions were analyzed. CD133 antibody used for the vesicle isolation was IgG produced in mouse, which was detected by anti-mouse IgG antibody, showing efficient capture by the beads. Despite the efficient capture, the DMSO-treated PLC cells did not have much CD133+ vesicle to be bound with the antibody. (I) EM image of Immunogold staining on the isolated vesicle. Scale bars, 100 μm (A), 25 μm (D), 1 μm (E, F, Fluorescence in G), 100 nm (EM in G), 50 nm (I).Figure 5—source data 1.Source data for western blot in panel H.Source data for western blot in panel H.Analyses of CD133 localization.(A–C) Immunofluorescence on PLC cells transfected with CD133-Myc-tag fusion protein expression construct. Cells with different expression levels are shown as representatives. In (A) and (C), exposure times for the CD133 signals were adjusted separately to clearly demonstrate the patterns, rather than intensities. Note that cells with higher CD133 expression displayed bulky patterns of the filaments, with maintained colocalization with tubulin filaments. Arrowheads, CD133+ filaments. As shown in (B), the overexpressed CD133 primarily localizes to the filaments, without detectable membrane localization (arrowheads). With extreme overexpression, CD133 can also localize to the cellular membrane surface, altering the morphology of the surface (right panels). (D) Immunofluorescence on HeLa and MC38 cells. (E) Colocalization of CD133 and β-tubulin was analyzed as Pearson’s coefficient. Mismatched green and magenta channels from shuffled ROIs were measured as controls. (F) Immunofluorescence on PLC cells transfected with cMet-GFP. cMet, an HGF receptor, shows the cell surface. CD133 did not colocalize with cMet-GFP on the cell surface, but instead localized to the filaments. (G) Immuno-Gold EM images of cryo-ultramicrotome sections of Shp2 knockout (SKO) liver tissue after partial hepatectomy (PHx). Light green arrowheads, CD133 staining (12 nm colloidal gold); Magenta arrowheads, α-tubulin staining (18 nm colloidal gold). Scale bars, 5 μm (A and C), 50 μm (B and D), 25 μm (F), and 50 nm (G).
less